• BFH772 (VEGFR2 inhibitor): Research Workflow

  2026-09-24

  BFH772 is a small-molecule VEGFR2 inhibitor for researchers testing VEGFR2-associated signaling and angiogenesis in controlled cell or animal-model workflows. Its organic-solvent solubility and limited dossier information on dosing make it unsuitable for water-only formulations or for studies that require a validated in vivo regimen without prior optimization.

• Tetrandrine Workflows for Calcium Signaling Research

  2026-09-24

  Use Tetrandrine as a DMSO-soluble natural-product probe to connect calcium-channel perturbation with electrophysiology, calcium imaging, and downstream cell responses. A staged dosing and control strategy helps distinguish channel-related effects from precipitation, vehicle effects, or loss of viability.

• DFCP1 Restrains ATGL-Driven Lipid Droplet Lipolysis

  2026-09-23

  The study identifies DFCP1 as a nutrient-sensitive regulator of lipid droplet breakdown: during starvation, it recruits ATGL to droplets but restricts ATGL mobility, slowing lipolysis. These findings distinguish DFCP1’s principal effect on lipolysis from its smaller contribution to lipophagy and suggest useful controls for studying lipid-droplet proteins in cell extracts.

• Ciprofloxacin–Tetracycline Antagonism

  2026-09-23

  The reference study uses microfluidic single-cell analysis to show that ciprofloxacin–tetracycline antagonism is driven largely by suppressed bacterial cell death rather than by a simple population-level growth effect. Its results connect nutrient-dependent growth, SOS-response heterogeneity, and survival, providing a framework for interpreting antibiotic combinations beyond bulk culture averages.

• Tropifexor: From FXR Activation to Barrier Assays

  2026-09-22

  Tropifexor (LJN452) is a potent FXR signaling pathway modulator with growing relevance to intestinal epithelial barrier function research. This article translates neonatal piglet and patient-derived organoid findings into a rigorous framework for selecting assays, controls, and translational models.

• WSP-5 for Live-Cell H2S Imaging

  2026-09-22

  WSP-5, or Washington State Probe-5, converts rapid H2S reactions into a practical fluorescence readout for live-cell imaging, donor-release studies, and diabetic cardiomyopathy models. This workflow-focused guide shows how to prepare, image, control, and troubleshoot the probe while connecting fluorescence data to disease-relevant endpoints.

• Sulfo-NHS-Biotin: Workflow and Troubleshooting

  2026-09-21

  Sulfo-NHS-Biotin enables fast, aqueous protein labeling for cell-surface phenotyping, affinity workflows, and immunoprecipitation. This guide connects its practical chemistry with SEC-seq-inspired single-cell secretion studies while clearly separating validated use cases from assay adaptations that require optimization.

• Lysoptosis: Serpins, Cathepsins, and Cell Death

  2026-09-21

  The reference study defines lysoptosis as a conserved lysosome-dependent cell-death pathway that becomes prominent when intracellular serpin inhibitors are absent. By comparing Caenorhabditis elegans, mouse, and human models, it links lysosomal membrane permeabilization and cathepsin L activity to a distinct execution program with implications for mechanistic cell-death research.

• U0126-EtOH: MEK1/2 Inhibitor Workflows

  2026-09-20

  U0126-EtOH provides a selective way to interrogate MEK1/2 and downstream ERK signaling in neuronal, inflammatory, and leukemia models. This guide converts its mechanism into practical workflows for oxidative stress research, pathway validation, assay controls, and troubleshooting.

• HyperScribe T7 High Yield RNA Synthesis Kit Guide

  2026-09-19

  Translate a T7 RNA polymerase transcription reaction into reproducible RNA probes, translation substrates, and mechanistic assays. This guide connects capped, biotinylated, and dye-labeled RNA workflows with the ROS–ferroptosis–inflammation biology of intervertebral disc degeneration while keeping study-derived findings separate from practical recommendations.

• BFH772 (VEGFR2 inhibitor): Practical Guide

  2026-09-18

  BFH772 is a selective small-molecule VEGFR2 inhibitor for experiments that require focused modulation of VEGFR2-associated angiogenic signaling. Its organic-solvent solubility and water insolubility make it more suitable for controlled DMSO- or ethanol-based workflows than for aqueous formulations or broad-spectrum kinase studies.

• Senescent CAFs Drive Breast Cancer Progression

  2026-09-18

  Ye and colleagues identify a senescent myofibroblast cancer-associated fibroblast population that suppresses natural killer cell cytotoxicity through extracellular-matrix remodeling and thereby promotes breast tumor growth. Genetic or pharmacologic removal of these senescent CAFs restored antitumor immune activity in mice, while human-tumor analyses linked the population to multiple breast cancer subtypes and ductal carcinoma in situ recurrence.

• Mouse Tissue Lysis Kit (K1038): Practical Guide

  2026-09-17

  The Mouse Tissue Lysis Kit (K1038) prepares lysates from mouse tissues such as tail, toe, or ear for direct PCR-based genotyping, avoiding a separate DNA extraction and purification step. It is intended for scientific molecular biology research and should not be used for diagnostic, clinical, or medical applications.

• E-64 for Cysteine Protease Assays

  2026-09-17

  E-64 is a covalent L-trans-epoxysuccinyl peptide probe for mapping cysteine protease activity in purified enzymes, lysates, and cell models. Its broad activity against papain-like proteases makes it useful for pathway suppression and assay validation, but the compound should be paired with genetic controls when interpreting cathepsin S biology in lymphoma.

• In Vitro Mammalian Embryonic Dormancy via mTOR

  2026-09-16

  The reference protocol establishes a noninvasive and reversible way to place mouse blastocysts, human blastoids, and mouse or human pluripotent stem cells into a diapause-like state through pharmacological mTOR inhibition. Its main practical contribution is to replace labor-intensive in vivo procedures with scalable culture workflows for studying developmental dormancy, pathway regulation, and recovery competence.

7973 records 1/532 page Next 12345 下5页 Last page